ISSN:

Journal Home

Stem Cell Research and Therapy Q1 Unclaimed

BioMed Central Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Stem Cell Research and Therapy is a journal indexed in SJR in Cell Biology and Medicine (miscellaneous) with an H index of 122. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1529 €. The scope of the journal is focused on translational research, therapeutics, stem cell research, clinical research, stem cell therapy, regenerative medicine. It has an SJR impact factor of 1,798 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,798.

Stem Cell Research and Therapy focuses its scope in these topics and keywords: cells, stem, mesenchymal, cell, human, differentiation, bone, adiposederived, marrow, maturation, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1) Cell Biology (Q1) Medicine (miscellaneous) (Q1) Molecular Medicine (Q1)

Price

1529 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,798

SJR Impact factor

122

H Index

369

Total Docs (Last Year)

1588

Total Docs (3 years)

25576

Total Refs

11883

Total Cites (3 years)

1580

Citable Docs (3 years)

6.97

Cites/Doc (2 years)

69.31

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cell Research Q1
Molecular Cell Q1
Nature Cell Biology Q1
Nature Microbiology Q1
Annual Review of Plant Biology Q1

Compare this journals